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Introduction
Height is a highly heritable and
classic polygenic trait. We
performed genome-wide analysis
for copy number variants (CNVs)
in children with idiopathic short
stature (ISS) using single
nucleotide polymorphism (SNP)
arrays, in an effort to identify novel
rare variants that may influence
height.
Results
CNVs were found in 43 patients, 6 (3.7%) with type I, 38 (23.5%) with one or more type II, 1 (0.6%) with type III, and type IV
or no CNVs were found in 119 patients (73.5%). The type I CNVs included 2 microdeletions and 2 microduplications
containing SHOX, and two terminal 15q deletions containing IGF1R + a type II CNV.
Type II CNVs
47 potentially pathogenic CNVs were observed in 38 patients, of whom two also have a type I CNV. Segregation analysis in
28 patients (37 CNVs) led to 4 de novo CNVs and 13 CNVs segregating with short stature. There was no segregation with
short stature in 20 CNVs.
Type II CNVs located near loci associated with height in GWAS
Five CNVs encountered in our study are close to loci associated with height in GWAS1: ADAMTS17, PRKG2/BMP3, PAPPA,
TULP4, and MKL2.
Bioinformatic approach
Rodent homologues of 5 genes in de novo CNVs were associated with GP phenotypes:
• Furin is expressed higher in GP, and upregulated from proliferative to hypertrophic zone.
• Fam3c is expressed higher in GP, downregulated from resting to proliferative zone, and increased with age.
• The de novo deletion near ADAMTS17 contained 3 genes of interest; Aldh1a3 is expressed highly in hypertrophic zone
compared to heart and lung; Lrrk1 is expressed higher in GP, and upregulated from proliferative to hypertrophic zone;
the expression of Chsy1 is high in hypertrophic zone, and downregulated with age.
miRNA
None of the 6 identified miRNAs in type II CNVs could be linked to short stature.
Conclusion
Whole genome SNP array
analysis identified known
pathogenic CNVs in 3.7% and
potentially pathogenic CNVs in
23.5% of patients with ISS. GWAS
and bioinformatic analysis
identified 10 candidate genes.
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Subjects and Methods
162 patients with a height of ≤ -2 SDS were analyzed with whole genome SNP arrays
(Affymetrix GeneChip Human Mapping 250K or Illumina HumanHap300 BeadChip arrays).
The CNVs were classified into 4 groups
I known pathogenic CNVs
II potentially pathogenic CNVs, not described in the Database of Genomic Variants (DGV)
III CNVs not described in the DGV, but not containing any protein-coding genes
IVknown polymorphic CNVs described in the DGV or observed in our in-house reference
set, at least 3 individuals must have been reported with the same rearrangement
Type IV CNVs were not further evaluated. All type II CNVs were assessed with Ensembl
and DECIPHER for gene and microRNA (miRNA) content and similar cases. If DNA from
the parents was available, segregation analysis was performed.
Bioinformatic approach
All CNVs were checked whether they were located in one of the chromosomal regions
associated with height in GWAS studies1.
For genes in de novo CNVs 3 additional approaches were used:
1) The rodent homologues were checked for 3 criteria:
- Higher expression in 1-wk-old mouse growth plate (GP) than in lung, kidney, and heart
- Spatial regulation: significant difference between zones in the 1-wk-old rat GP
- Temporal regulation: significant difference between 3 and 12 wks of age in the rat GP
2) Associations were investigated for mouse GP-related phenotypes
3) Associations with human GP-related phenotypes were investigated
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